Concepedia

Susan C. Low

SC

19

Publications

3.5K

Citations

16

H-Index

1994

Active since

Affiliations

Biogen (United States)(Current)

Harvard University

Brigham and Women's Hospital

University of North Carolina at Chapel Hill

The Barbara Ann Karmanos Cancer Institute

Susan C. Low is an author at Biogen (United States) specializing in medicine, pharmacology, and engineering.

Top concepts

Publications per year

1994–2025

19

Publications

19

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Jeffrey S. Hrkach, Daniel D. Von Hoff, Mir Mukkaram Ali et al. · Science Translational Medicine · 2012 · 1.1K citations

Knowing when not to stop: selenocysteine incorporation in eukaryotes

Susan C. Low, Marla J. Berry · Trends in Biochemical Sciences · 1996 · 433 citations

, , +7

Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors

Daniel D. Von Hoff, Monica Mita, Ramesh K. Ramanathan et al. · Clinical Cancer Research · 2016 · 262 citations

Design and testing of a humanized porcine donor for xenotransplantation

R. Anand, Jacob V. Layer, Dávid Héja et al. · Nature · 2023 · 235 citations · Full text

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway

Alan J. Bitonti, Jennifer Dumont, Susan C. Low et al. · Proceedings of the National Academy of Sciences · 2004 · 227 citations · Full text

Rows per page

1–5 of 19